x

Health

Japan Approves Novavax as 4th COVID Vaccine amid New Surge

TOKYO — Japan’s health ministry on Tuesday formally approved Novavax’s COVID-19 vaccine, a fourth foreign-developed tool to combat the infections as the country sees signs of a resurgence led by a subvariant of fast-spreading omicron.

The ministry approval comes the day after its experts panel endorsed use of Novavax’s protein vaccine, which is designed with similar technology used to fight diseases such as the flu and hepatitis B, for the first two shots and a booster.

Health Minister Shigeyuki Goto told reporters that Novavax product adds variety to the choices available and could appeal to those who are hesitant to use COVID-19 vaccines such as Pfizer’s and Moderna’s, which are designed with newer technologies.

Jabs using Novavax vaccine are expected to start as early as late May.

Japan reported 24,164 new cases Monday, according to the health ministry. Japan in March lifted all COVID-19 restrictions as the infections slowed significantly, but experts noted signs of a resurgence in a number of prefectures during a season of traveling and parties for people marking graduation and the start of the academic and business year.

The government is trying to expand businesses and get the pandemic-hit economy back on track. Japan is slowly easing the border controls following sharp criticisms for its longtime restrictions on non-resident foreign students, scholars and business people, but Prime Minister Fumio Kishida has said Japan is not considering restarting inbound tourism anytime soon.

Booster shots have been slow in Japan and less than 50% of the population had received booster shots of mainly mRNA vaccines from Pfizer and Moderna. A third vaccine, AstraZeneca, is hardly used due to public concern about reports of rare blood clotting and is largely donated to vaccine-scarce Asian countries bilaterally or through a United Nations-backed program. About 80% of the Japanese elderly population had received three shots.

Goto said Japan has agreed to purchase 150 million doses of the Novavax shots developed by the Maryland company, which will help stabilize vaccine supply in a country that fully relies on foreign imports while development of its own vaccines have fallen behind. Novavax’s distributor in Japan, Takeda Pharmaceutical Co., is to locally manufacture 250 million doses annually.

RELATED

Summer is the season of smoky BBQs, sweet corn on the cob and juicy watermelon slices.

Top Stories

Columnists

A pregnant woman was driving in the HOV lane near Dallas.

General News

NEW YORK – Meropi Kyriacou, the new Principal of The Cathedral School in Manhattan, was honored as The National Herald’s Educator of the Year.

Video

It’s Not as World-Famous as Ramen or Sushi. But the Humble Onigiri is Soul Food in Japan

TOKYO (AP) — The word “onigiri” became part of the Oxford English Dictionary this year, proof that the humble sticky-rice ball and mainstay of Japanese food has entered the global lexicon.

NEW JERSEY – The Hellenic Federation of New Jersey held its 11th Annual Awards Gala on June 23 at the Greek-owned catering hall The Graycliff.

LEIPZIG, Germany  — Italy substitute Mattia Zaccagni scored in the last minute of stoppage time for Italy to advance to the knockout stage of the European Championship after drawing Croatia 1-1 on Monday.

DUESSELDORF, Germany  — Spain changed almost its entire lineup and still kept up its victorious start to the European Championship with a 1-0 win over Albania, which was eliminated on Monday.

ATHENS, Greece  — Greece on Monday accused neighboring North Macedonia’s new center-right government of breaking a historic deal on the country’s name, warning that this could harm its hopes of one day joining the European Union.

Enter your email address to subscribe

Provide your email address to subscribe. For e.g. [email protected]

You may unsubscribe at any time using the link in our newsletter.